Cara Therapeutics, Inc. (CARA) Stock Ratings

View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


100% of 2 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
LBcamera LBcamera 04/13/2017 3 months $17.53 $19.88 +13.41% 13 Active
Comments: All trials phases have been positive so far expect this to continue
Pam DeBoy Pam DeBoy 12/24/2016 3 months $9.97 $16.09 +61.38% 61 Ended
Comments: Love product potential but realize this is an all or nothing play
thankgod4love58 thankgod4love58 11/21/2016 1 week $11.97 $9.83 -17.88% -17 Ended
Comments: Upcoming product launch will be successful ... Read the full entry
ToddNims ToddNims 10/13/2016 3 months $8.00 $11.14 +39.25% 39 Ended
djwhilby djwhilby 08/21/2016 1 Year $5.91 $19.88 +236.38% 236 Active
TheyCallMeG8tor TheyCallMeG8tor 03/19/2015 1 Year $10.62 $4.96 -53.27% -53 Ended
Comments: Kappa and CB agonists? HUGE potential as CB's and non-abusable opes enter pain & inflammation mkt.
Biotech_Invest Biotech_Invest 12/24/2014 1 Year $9.78 $15.60 +59.51% 59 Ended
Comments: CARA's pain killer CR845 has a huge market potential (especially if IV form is converted to oral)
markkabbash markkabbash 10/29/2014 3 months $8.65 $11.03 +27.51% -27 Ended

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.